Key Insights: Robert Kiyosaki has warned Bitcoin buyers to avoid hype-driven decisions as BTC trades under renewed pressure. Bitcoin, which has just touched a sevenKey Insights: Robert Kiyosaki has warned Bitcoin buyers to avoid hype-driven decisions as BTC trades under renewed pressure. Bitcoin, which has just touched a seven

Bitcoin Price Faces Pressure as Kiyosaki Urges Buyer Caution

2026/06/01 03:30
4 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
bitcoin price robert kiyosaki btc crypto

Key Insights:

  • Buyers face Kiyosaki’s warning as Bitcoin price weakens.
  • Kiyosaki says buyers should avoid hype-driven decisions.
  • Traders are watching $71K support and the $79K recovery zone.

Robert Kiyosaki has warned Bitcoin buyers to avoid hype-driven decisions as BTC trades under renewed pressure. Bitcoin, which has just touched a seven-week low of approximately $72,000, has been trading around $73,800.

The drop followed a weaker risk appetite linked to U.S.-Iran tensions, ETF outflows, and leveraged liquidations. BTC is now down about 3% over the past 7 days, keeping traders focused on support levels.

Bitcoin Buyers Get Cautious Signal as BTC Weakens

Kiyosaki used the latest Bitcoin price correction to push a familiar message with a sharper tone. The author of Rich Dad Poor Dad said investors should not buy any asset without education, timing, and a clear plan.

Source : XSource : X

His comments came as Bitcoin struggled to regain short-term strength after a three-day slide. The market had already recovered from a yearly low near $60,000 in early February. However, traders still question whether that low marked the cycle bottom.

Kiyosaki has long backed Bitcoin, Ethereum, gold, and silver. Yet he focused less on bold targets and more on investor discipline. He said safe assets can still create losses when buyers enter blindly.

He also criticized financial planners who describe U.S. government bonds as safe. Kiyosaki said there is “nothing safe” from poor thinking. His central point was simple: the strongest asset is still financial knowledge.

Buyers Watch Support After Recent Bitcoin Price Drop

Bitcoin buyers are watching the $71,000 area as the next major test. Analyst Michael van de Poppe says BTC is near a pivotal level. He warned that a failed hold around $71,000 could open the door to prices below $65,000.

However, Van de Poppe said the current setup differs from the February breakdown. If Bitcoin gets support, he said BTC could push toward $76,600. That move may also support a broader altcoin recovery.

Market pressure remains clear across several signals. Bitcoin stabilized near $73,000 after geopolitical tension weighed on sentiment. The liquidations and the ETF outflows also played a heavy role during the pullback.

Bitcoin price daily chart | Source: Michael van de Poppe on XBitcoin price daily chart | Source: Michael van de Poppe on X

The chart still leaves traders cautious. BTC has not yet built a strong recovery above nearby resistance. As a result, the market wants proof that buyers can defend BTC support before chasing upside.

Some traders are also watching the $79,000 zone for a stronger recovery signal. A move toward that area would suggest renewed demand. Until then, the Bitcoin price correction keeps short-term risk elevated.

Kiyosaki’s warning stands out because he often encourages investors to buy scarce assets during fear. His latest message does not reject Bitcoin. Instead, it tells Bitcoin buyers to understand risk before following market excitement.

Kiyosaki has also urged investors to watch global cash flows. He pointed to major holders, including Japan and China, reducing U.S. bond exposure. He said that a stronger interest in gold and silver indicates distrust of paper assets.

Kiyosaki has often criticized fiat currency, U.S. bonds, and retirement products tied to traditional markets. In his view, debt growth and inflation continue to weaken purchasing power. That explains his preference for hard assets over conventional savings plans.

Still, his forecasts often draw debate. He recently suggested Bitcoin could reach $750,000 and Ethereum could hit $95,000 after a major crash. Critics argue that some of his past timing calls missed their expected windows.

Kiyosaki has also said he is not a financial advisor. He tells followers that he shares what he buys and why, but each investor must decide for themselves.

The post Bitcoin Price Faces Pressure as Kiyosaki Urges Buyer Caution appeared first on The Coin Republic.

Market Opportunity
Bitcoin Logo
Bitcoin Price(BTC)
$72,973.25
$72,973.25$72,973.25
-0.91%
USD
Bitcoin (BTC) Live Price Chart

SPACEX(PRE) Launchpad

SPACEX(PRE) LaunchpadSPACEX(PRE) Launchpad

Register for a chance to win a free lucky draw

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Bitcoin shorts risk $2.5 billion liquidation at $72K: Are bears in danger?

Bitcoin shorts risk $2.5 billion liquidation at $72K: Are bears in danger?

Bitcoin is poised for a reversal if ETF demand returns or a ceasefire occurs, potentially crushing short sellers in a massive price squeeze.
Share
Coin Telegraph2026/04/04 19:58
Robotics Automation Prototyping: Engineering Kinetic Agility into End-Effectors

Robotics Automation Prototyping: Engineering Kinetic Agility into End-Effectors

Inertia is the invisible tax on modern industrial throughput. Every millisecond a robotic arm spends decelerating, or waiting for high-frequency vibrations to settle
Share
Techbullion2026/04/02 18:25

RealStocks Now Live

RealStocks Now LiveRealStocks Now Live

Trade real U.S. stock via regulated brokerage